Personal Income Pulls Back as Government Benefits Weaken
Despite a massive recovery in the stock market and trillions of dollars of stimulus, the U.S. economy is firmly in a recession. Friday’s round of economic numbers seemed to reflect this.
All Work
Chris Lange
What Merger Hopes Mean for MDC Partners Stock
MDC Partners shares more than doubled on Friday after the company announced that it may be looking intently at a merger with Stagwell Media.
Albertsons Finally Gets Around to Coming Public
Albertsons has priced its initial public offering below the expected price range. Look for the food and drug retailer to come public later on Friday.
Nike’s Incredible Digital Sales Fail to Offset Store Closures
Nike released disappointing fiscal fourth-quarter financial results after the markets closed on Thursday, and shares slipped early Friday.
6 Stocks to Buy With Major Upside in Rising Secular E-Commerce Shifts
E-commerce has been perhaps the biggest winner from the coronavirus pandemic. These stocks are expected to benefit greatly from this accelerating trend.
Durable Goods Report Shines Despite Pandemic Woes
The U.S. Census Bureau released its May advance report on durable good manufacturers’ shipments, inventories and orders on Thursday morning.
Q1 GDP Fails to Impress or Surprise
The U.S. economy shrank by 5% during the first quarter, according to the Bureau of Economic Analysis.
Weekly Jobless Claims Continue to Hit Over a Million
Weekly jobless claims continued to pile up for the week ending June 20, again hitting over 1 million for the week.
Short Sellers Run for Cover From Major Biotechs
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Is Semiconductor Short Interest Signaling a Market Rally?
The June 15 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
Is Amazon for Real About Fighting Counterfeits This Time?
Amazon announced early on Wednesday that it has established a new Counterfeit Crimes Unit, dedicated to bringing to justice counterfeiters that violate the law and Amazon’s policies.
Why This FDA Update Is Crucial for Fulcrum Therapeutics and COVID-19
The FDA has notified Fulcrum Therapeutics that it is allowed to proceed with initiating its Phase 3 trial of losmapimod in higher risk hospitalized adults with COVID-19.
Is the Nintendo Switch About to Be Overrun by Competition?
Nintendo always has been one of the major players in the video game industry, but this year it may be outmatched as the holiday season is on the way.
GW Pharma Makes Big Regulatory Step for Cannabidiol in UK
GW Pharmaceuticals took a big step forward for the development of its cannabidiol product in the United Kingdom.
Existing Home Sales Continue to Drop, but Realtors Are Optimistic
Existing home sales plunged in May, according to the National Association of Realtors. But does this represent a bottom in the market?
Why This Capital Injection Is Huge for Inovio
Inovio Pharmaceuticals has announced that it received $71 million in funding from the U.S. Department of Defense to support the production of its delivery device for the COVID-19 vaccine.
How Salesforce and Siemens Aim to Fight COVID-19
Salesforce.com is looking to get people back to work in the age of COVID with a recently announced a strategic partnership with Siemens.
Why the Sanofi and Translate Bio Vaccine Pact Is Win-Win
Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to expand their existing 2018 collaboration and license agreement
Gold Bugs Have to Be Happy With This
Gold is making a great case for itself this year, and gold bugs have to be happy about that. The strategists at JPMorgan have a bullish view on gold.
Should Investors Trust Bill Ackman With This Blank Check IPO?
Pershing Square Tontine Holdings has filed with the SEC regarding its initial public offering.